TP53 and urinary bladder cancer: Interactions between nuclear DDX31, mutant p53, and nucleolar proteins have been reported to modulate EGFR signaling in bladder cancer and increased cytosolic expression of DDX31 and mutant p53 have been implicated in poorer prognosis34.